Toggle navigation
Help
Preferences
Sign up
Log in
Advanced
Neoaltto PowerPoint PPT Presentations
Grid
List
All Time
All Time
Added Today
Added This Week
Added This Month
Show:
All Time
Added Today
Added This Week
Added This Month
Recommended
Recommended
Relevance
Latest
Highest Rated
Most Viewed
Sort by:
Recommended
Relevance
Latest
Highest Rated
Most Viewed
Featured Presentations
Search Results
Overcoming Resistance to HER2-Targeted Therapy in Patients With Advanced Breast Cancer
- Title: Overcoming Resistance to HER2-Targeted Therapy in Patients With Advanced Breast Cancer Author: SOluku Last modified by: IMGTemp Created Date
Title: Overcoming Resistance to HER2-Targeted Therapy in Patients With Advanced Breast Cancer Author: SOluku Last modified by: IMGTemp Created Date
| PowerPoint PPT presentation | free to download
PRACTICE CHANGING BIG
- PRACTICE CHANGING BIG
PRACTICE CHANGING BIG
| PowerPoint PPT presentation | free to view
First Results of the NeoALTTO Trial (BIG 01-06/EGF 106903): A Phase III, Randomized, Open-Label, Neoadjuvant Study of Lapatinib, Trastuzumab, and Their Combination Plus Paclitaxel in Women with HER2-Positive Primary Breast Cancer
- Dual blockage of HER2 is a valid ... from the study published by Dr Blackwell in the Journal of Clinical Oncology earlier ... Study Endpoints ...
Dual blockage of HER2 is a valid ... from the study published by Dr Blackwell in the Journal of Clinical Oncology earlier ... Study Endpoints ...
| PowerPoint PPT presentation | free to download
Page
of